Home » Stocks » ZSAN

Zosano Pharma Corporation (ZSAN)

Stock Price: $1.01 USD 0.04 (3.76%)
Updated Jun 17, 2021 12:32 PM EDT - Market open
Market Cap 107.26M
Revenue (ttm) 482,000
Net Income (ttm) -32.82M
Shares Out 104.36M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 17
Last Price $1.01
Previous Close $0.97
Change ($) 0.04
Change (%) 3.76%
Day's Open 0.98
Day's Range 0.97 - 1.02
Day's Volume 1,456,832
52-Week Range 0.33 - 3.06

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

ZSAN stock is zooming higher on Thursday after Zosano Pharma shared positive data on its proprietary migraine treatment. The post ZSAN Stock: Why Zosano Pharma Is Racing Higher Today appeared first on I...

3 weeks ago - InvestorPlace

Nano-cap Zosano Pharma Corporation (NASDAQ: ZSAN) has announced that long-term data for Qtrypta, as an acute treatment of migraine, published in The Journal of Headache and Pain. The tolerability and ef...

3 weeks ago - Benzinga

FREMONT, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that an article titled, “Long Term Safety, Tolerabi...

3 weeks ago - GlobeNewsWire

FREMONT, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the appointment of Kathy McGee, an accomplished bio...

3 weeks ago - GlobeNewsWire

FREMONT, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March...

1 month ago - GlobeNewsWire

As April comes to an end, are these 3 penny stocks worth watching? The post 3 Penny Stocks to Watch During the Last Week of April appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...

Other stocks mentioned: AEZS, MICT
1 month ago - PennyStocks

So, which biotech penny stocks, popular with the Reddit set, offer such opportunity? Consider these seven as ones with potential to live up to online enthusiasm.

Other stocks mentioned: ATNF, CTXR, JAGX, OCGN, SVRA, TMBR
2 months ago - InvestorPlace

Reddit stocks -- and in particular Reddit penny stocks -- are some of the riskiest shares out there. Yet, investors could make out big with some of the names on this list.

Other stocks mentioned: LPCN, OGI, SNDL, SVRA, YVR, ZOM
2 months ago - InvestorPlace

FREMONT, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and year...

3 months ago - GlobeNewsWire

FREMONT, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer, S...

3 months ago - GlobeNewsWire

FREMONT, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the company has received the official Type A ...

3 months ago - GlobeNewsWire

Zosano Pharma (ZSAN) stock is flying high on Tuesday with heavy trading despite there being a lack of news about the company. The post ZSAN Stock: 9 Things to Know About Zosano Pharma as Shares Fly High...

4 months ago - InvestorPlace

FREMONT, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that early onset of action data for Qtrypta™, Zosa...

4 months ago - GlobeNewsWire

Zosano Pharma (ZSAN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

5 months ago - Zacks Investment Research

News that migraine-treatment maker Zosano Pharma will reapproach the FDA for approval has ZSAN stock jumping this morning. Investors should be cautious as penny stocks can cause big headaches.

5 months ago - InvestorPlace

FREMONT, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that on December 30, 2020 the company requested a ...

5 months ago - GlobeNewsWire

FREMONT, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive officer, St...

5 months ago - GlobeNewsWire

LOS ANGELES--(BUSINESS WIRE)---- $ZSAN #ZSAN--DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Zosano Pharma Corporation.

5 months ago - Business Wire

New York, New York--(Newsfile Corp. - December 28, 2020) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zosano Pharma Corporation ("Zosano" or...

5 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - December 28, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between Feb...

5 months ago - Newsfile Corp

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zosano Pharma Corporation ("Zosano" or the "Company") (NASDAQ: ZSAN) a...

5 months ago - Business Wire

New York, New York--(Newsfile Corp. - December 26, 2020) - Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation ("Zosano" or the "Company") (NASDAQ: ZSAN)...

5 months ago - Newsfile Corp

NEW YORK, Dec. 25, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United S...

5 months ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - December 24, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of ...

5 months ago - Newsfile Corp

NEW YORK, Dec. 24, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between February 13, 2017 and ...

5 months ago - PRNewsWire

New York, New York--(Newsfile Corp. - December 24, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Zosano Pharma Corporation (NASDAQ: ZSAN)...

5 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - December 23, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of ...

5 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - December 23, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between Feb...

5 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - December 22, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of ...

5 months ago - Newsfile Corp

Investors with losses are encouraged to contact the firm before December 28, 2020 ; click here to submit trade information

5 months ago - GlobeNewsWire

NEW YORK--(BUSINESS WIRE)-- #ClassAction--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United Sta...

5 months ago - Business Wire

NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Zosano Pharma Corporation (NASDAQ: ZSAN...

5 months ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - December 21, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of ...

5 months ago - Newsfile Corp

NEW YORK, Dec. 19, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation (“Zosano” or the “Company”) (NASDAQ: ZSAN) and certain of...

5 months ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - December 17, 2020) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of...

5 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - December 17, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between Fe...

5 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - December 17, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Zosano Pharma Corporation (NASDAQ: ZSAN)...

5 months ago - Newsfile Corp

LOS ANGELES, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 28, 2020 deadline to file a lead plaintiff motion in the class action filed ...

6 months ago - GlobeNewsWire

NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between February 13, 2017 ...

6 months ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - December 15, 2020) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of...

6 months ago - Newsfile Corp

NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Zosano Pharma Corporation (NASDAQ: ZSAN...

6 months ago - GlobeNewsWire

New York, New York--(Newsfile Corp. - December 14, 2020) - Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation ("Zosano" or the "Company") (NASDAQ: ZSAN)...

6 months ago - Newsfile Corp

LOS ANGELES, Dec. 14, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming December 28, 2020 deadline to file a lead plaintiff motion in the class action filed on b...

6 months ago - PRNewsWire

NEW YORK, Dec. 13, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation (“Zosano” or the “Company”) (NASDAQ: ZSAN) and certain of...

6 months ago - GlobeNewsWire

NEW YORK, Dec. 12, 2020 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Zosano Pharma Corporation (NASDAQ: ZSAN) between February 1...

6 months ago - GlobeNewsWire

NEW YORK, Dec. 10, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between February 13, 2017 and ...

6 months ago - PRNewsWire

New York, New York--(Newsfile Corp. - December 10, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Zosano Pharma Corporation (NASDAQ: ZSAN)...

6 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - December 9, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Z...

6 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - December 8, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Zosano Pharma Corporation (NASDAQ: ZSAN) ...

6 months ago - Newsfile Corp

NEW YORK, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Zosano Pharma Corporation (NASDAQ: ZSAN...

6 months ago - GlobeNewsWire

About ZSAN

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.

Industry
Biotechnology
IPO Date
Jan 27, 2015
CEO
Steven Lo
Employees
45
Stock Exchange
NASDAQ
Ticker Symbol
ZSAN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for Zosano Pharma stock is "Buy." The 12-month stock price forecast is 2.17, which is an increase of 115.28% from the latest price.

Price Target
$2.17
(115.28% upside)
Analyst Consensus: Buy